急性冠状动脉综合征:机制,挑战和新的机会
Simon Kraler1,2, Christian Mueller3,4, Peter Libby5
1Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.
European heart journal
|May 13, 2025
概括
急性冠状动脉综合征 (ACS) 除了斑块破裂之外还有各种原因. 个性化医疗,包括人工智能等新技术,对于改善ACS管理中的诊断和患者结果至关重要.
科学领域:
- 心血管医学 心血管医学
- 精准医学是一门精准的医学.
- 医疗技术 医疗技术 医学技术
背景情况:
- 动脉样硬化仍然是全球主要的死亡原因,急性冠状动脉综合征 (ACS) 是主要的后果.
- 传统的ACS机制 (斑块破裂/侵蚀) 是不够的;不同的病因,如结节和微血管功能障碍.
- 现有的ACS管理通常依赖于有限的诊断数据,需要更全面的方法.
研究的目的:
- 提供ACS机制的最新审查,包括低估的贡献者和性别差异.
- 探索用于个性化ACS管理的新型诊断和预后工具.
- 倡导采用精准医学方法,整合先进技术,改善患者护理.
主要方法:
- 审查关于ACS机制和管理策略的当前文献.
- 对不断发展的成像技术,生物标志物和风险预测得分 (例如,Code-ACS,MI3,PRAISE,GRACE,SEX-SHOCK) 的分析.
- 在ACS诊断和预后中探索机器学习和人工智能应用.
主要成果:
- ACS表现出显著的异质性,多种机制有助于其发生.
- 越来越多地认识到ACS特征的性别特异性差异.
- 新兴技术,包括人工智能,为增强诊断和个性化风险分层提供了潜力.
结论:
- 准确医学的范式转变对于管理ACS异质性至关重要.
- 以机械洞察力和先进技术为基础的个性化患者护理是改善长期结果的关键.
- 需要对人工智能等创新技术进行进一步的研究,以优化ACS中的临床决策.
相关概念视频
01:17Ischemic Heart Disease: Overview
1.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
397
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
397
01:16Antianginal Drugs: Nitrates and β-Blockers
449
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
449
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
396
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
396
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
1.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.9K